药明康德收盘下跌1.28%，滚动市盈率20.09倍，总市值1898.57亿元

Core Viewpoint - WuXi AppTec's stock closed at 65.74 yuan, down 1.28%, with a rolling PE ratio of 20.09 times and a total market capitalization of 189.857 billion yuan [1] Group 1: Company Performance - For the fiscal year 2024, WuXi AppTec reported revenue of 39.241 billion yuan, a year-on-year decrease of 2.73%, and a net profit of 9.450 billion yuan, down 1.63% year-on-year [1] - The company's gross profit margin stands at 41.48% [1] Group 2: Market Position - WuXi AppTec ranks 15th in the medical services industry, which has an average PE ratio of 44.19 times and a median of 43.02 times [1] - The company has 272 institutional investors holding a total of 1,078.2579 million shares, with a combined market value of 59.347 billion yuan [1] Group 3: Business Overview - WuXi AppTec specializes in providing integrated, end-to-end drug research and production services for the global pharmaceutical and life sciences industries [1]